WO2009090544A3 - Procédé de production d'atorvastatine calcique amorphe - Google Patents

Procédé de production d'atorvastatine calcique amorphe Download PDF

Info

Publication number
WO2009090544A3
WO2009090544A3 PCT/IB2009/000068 IB2009000068W WO2009090544A3 WO 2009090544 A3 WO2009090544 A3 WO 2009090544A3 IB 2009000068 W IB2009000068 W IB 2009000068W WO 2009090544 A3 WO2009090544 A3 WO 2009090544A3
Authority
WO
WIPO (PCT)
Prior art keywords
atorvastatin calcium
amorphous atorvastatin
producing amorphous
producing
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/000068
Other languages
English (en)
Other versions
WO2009090544A2 (fr
Inventor
P. V. Srinivas Rao
Yogendra Kumar Chauhan
Tushar Kumar Srivastava
Purna Chandra Ray
Om Dutt Tyagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Laboratories Ltd
Original Assignee
Matrix Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Ltd filed Critical Matrix Laboratories Ltd
Publication of WO2009090544A2 publication Critical patent/WO2009090544A2/fr
Publication of WO2009090544A3 publication Critical patent/WO2009090544A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé amélioré pour la production d'atorvastatine calcique amorphe ainsi qu'un procédé de conditionnement associé.
PCT/IB2009/000068 2008-01-16 2009-01-15 Procédé de production d'atorvastatine calcique amorphe Ceased WO2009090544A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN138/CHE/2008 2008-01-16
IN138CH2008 2008-01-16

Publications (2)

Publication Number Publication Date
WO2009090544A2 WO2009090544A2 (fr) 2009-07-23
WO2009090544A3 true WO2009090544A3 (fr) 2009-11-19

Family

ID=40885714

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/000068 Ceased WO2009090544A2 (fr) 2008-01-16 2009-01-15 Procédé de production d'atorvastatine calcique amorphe

Country Status (1)

Country Link
WO (1) WO2009090544A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083638A1 (fr) * 2001-04-11 2002-10-24 Cadila Healthcare Limited Procede de production d'atorvastatine calcique sous forme amorphe
WO2005090301A1 (fr) * 2004-03-17 2005-09-29 Ranbaxy Laboratories Limited Forme cristalline d'hemi-calcium d'atorvastatine
WO2006039441A2 (fr) * 2004-09-30 2006-04-13 Dr. Reddy's Laboratories Ltd. Atorvastatine calcique amorphe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083638A1 (fr) * 2001-04-11 2002-10-24 Cadila Healthcare Limited Procede de production d'atorvastatine calcique sous forme amorphe
WO2005090301A1 (fr) * 2004-03-17 2005-09-29 Ranbaxy Laboratories Limited Forme cristalline d'hemi-calcium d'atorvastatine
WO2006039441A2 (fr) * 2004-09-30 2006-04-13 Dr. Reddy's Laboratories Ltd. Atorvastatine calcique amorphe

Also Published As

Publication number Publication date
WO2009090544A2 (fr) 2009-07-23

Similar Documents

Publication Publication Date Title
PL2259972T3 (pl) Zespół wykrojów z tektur, pudełko i sposób wytwarzania pudełka za pomocą takich wykrojów
PL2081714T3 (pl) Sposób wytwarzania produktów z amorficznego metalu
PL2094910T5 (pl) Sposób wytwarzania produktu papierowego
EP2050733A4 (fr) Procédé de purification d'acide hydroxycarboxylique, procédé de production d'ester cyclique et procédé de production de poly(acide hydroxycarboxylique)
WO2010021738A3 (fr) Procédé pour la fabrication de collagène doublement réticulé
ZA201001999B (en) Set of blanks, box and production method
IL243864A (en) Method for making sucrose solution and method for making amorphous sucrose
GB0815593D0 (en) Packaging container, blank and method of forming a packaging container
AU2009232967A8 (en) Agrobacterium-mediated method for producing transformed plant
EP2347758A4 (fr) Procédé d'obtention d'une composition de rosuvastatine calcique et produit obtenu
EP2456545B8 (fr) Procédé de production d'une membrane et membrane ainsi produite
EP2326742B8 (fr) Utilisation d'une cible pour le dépôt par évaporation par arc, et procédé de fabrication d'une cible convenant à cette utilisation
WO2010121877A3 (fr) Procédé de préparation de l'olopatadine
WO2007099552A3 (fr) Nouvelle forme cristalline d'atorvastatine hémi-magnésium
GB0800929D0 (en) Blank for forming carton and method of making same
IL191919A0 (en) Process for preparing a crystalline form of atorvastatin hemi-calcium
GB2475969B (en) Blank for producing a package of tobacco articles, and method of producing a package of tobacco articles from such a blank
EP2424688B8 (fr) Procede de fabrication de produits allonges en titane
EP2265399A4 (fr) Moule et son procédé de fabrication
EP2451566A4 (fr) Système de production de la l-homophénylalanine et procédé de production de la l-homophénylalanine
EP2334667A4 (fr) Procédé de préparation d acétonide de rosuvastatine calcique
IL178574A0 (en) Process for forming amorphous atorvastatin calcium
EP2178223B8 (fr) Procédé de réception d'un signal et procédé de transmission correspondant
AU2008904347A0 (en) Method of Promoting a Product
AU2005904177A0 (en) Method of forming tamper evident packaging

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09702387

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09702387

Country of ref document: EP

Kind code of ref document: A2